GL1X · GenesisL1 explorer

MolNFT v1 · #182930 · protein

AlphaFold monomer V2.0 prediction for intracellular exo- alpha-(1->5)-L-arabinofuranosidase (A3DIH0)

A3DIH0: “AlphaFold monomer V2.0 prediction for intracellular exo- alpha-(1->5)-L-arabinofuranosidase (A3DIH0)”. MolNFT v1 #182930 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
A3DIH0
Type
protein
Length
503 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x1b399A5111673d28Cf7cc78c1b3eBE7668606558
UniProt
A3DIH0

Structure

1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein503—A3DIH0

Compared structures

  • 5O7Z · Crystal structure of R67A mutant of alpha-L-arabinofuranosidase ARA51 from clostridium… · an experimental structure of the same protein · chain A against A, TM-score 0.99
  • 5O7Z · Crystal Structure of R67A Mutant of alpha-L-arabinofuranosidase Ara51 from Clostridium… · an experimental structure of the same protein · chain A against A, TM-score 0.99
  • 5O82 · Crystal Structure of R67A/E173A Mutant of alpha-L-arabinofuranosidase Ara51 from… · an experimental structure of the same protein · chain A against B, TM-score 0.98
  • 5O82 · Crystal structure of R67A/E173A mutant of alpha-L-arabinofuranosidase ARA51 from… · an experimental structure of the same protein · chain A against B, TM-score 0.98
  • 5O80 · Crystal structure of R67A mutant of alpha-L-arabinofuranosidase ARA51 from clostridium… · an experimental structure of the same protein · chain A against A, TM-score 0.98
  • 5O81 · Crystal Structure of R67A/E173A Mutant of alpha-L-arabinofuranosidase Ara51 from… · an experimental structure of the same protein · chain A against A, TM-score 0.98
  • 5O81 · Crystal structure of R67A/E173A mutant of alpha-L-arabinofuranosidase ARA51 from… · an experimental structure of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.